Ferium 50 Mg/ml Injection 10 ml (Ferric Carboxymaltose)
Price range: $488.60 through $1,364.60Required
| Pack Size | Price | Unit Price | Quantity | |
|---|---|---|---|---|
| 3 Injection | $488.60 | $162.87 / injection | ||
| 6 Injection | $928.90 | $154.82 / injection | ||
| 9 Injection | $1,364.60 | $151.62 / injection |
About Ferium 50 Mg/ml Injection 10 ml (Ferric Carboxymaltose)
Medicine information
- Active ingredient
- Ferric carboxymaltose
- Delivery time
- 10–14 business days after dispatch for the United States, United Kingdom, Canada, and Australia; other destinations vary under the store shipping framework. Delivery estimates are not guaranteed and may be extended by customs or local carrier delays. Cheap_Generic_Med_Shipping_Coun…
- Indication
- Iron replacement treatment for iron deficiency anemia when intravenous iron is clinically appropriate, including patients who cannot tolerate oral iron or have had an unsatisfactory response to it. Ferric carboxymaltose also has established indications in some jurisdictions for iron deficiency associated with non-dialysis-dependent chronic kidney disease and certain adults with heart failure.
- Manufacturer
- Emcure Pharmaceuticals Ltd.
- Packaging
- 10 mL vial containing 500 mg elemental iron as ferric carboxymaltose (50 mg/mL), 1 vial.
- Strength
- 50 mg/mL
- Dosage form
- Injection solution
- Route
- Intravenous
Medicine overview
Ferium 50 mg/mL Injection 10 mL contains ferric carboxymaltose, an intravenous iron replacement medicine. Each 10 mL vial provides 500 mg of elemental iron at a concentration of 50 mg/mL. It is used to replenish iron when intravenous replacement is appropriate, particularly in iron deficiency anemia when oral iron cannot be used effectively or has not produced an adequate response. The medicine must be administered intravenously by a healthcare professional.
What it is used for
Ferric carboxymaltose replaces depleted iron stores and is primarily used for iron deficiency anemia when oral iron is unsuitable, poorly tolerated, or insufficient. Depending on the jurisdiction and patient group, ferric carboxymaltose is also indicated for iron deficiency associated with non-dialysis-dependent chronic kidney disease and for certain adults with iron deficiency and symptomatic heart failure. The reason for iron deficiency should be assessed as part of medical care.
How it works
Ferric carboxymaltose is an iron-carbohydrate complex that delivers iron directly into the bloodstream. After administration, the complex is taken up and the iron becomes available for normal iron-dependent processes. The body can incorporate this iron into hemoglobin, the protein in red blood cells that carries oxygen, and replenish iron stores. This helps correct iron deficiency and supports production of healthy red blood cells when iron deficiency anemia is present.
How it is taken
Ferium is given intravenously by a trained healthcare professional; it is not intended for self-injection. Ferric carboxymaltose may be administered as a slow intravenous injection or an intravenous infusion according to the prescribed dose and applicable product instructions. Patients should be monitored during administration and for at least 30 minutes afterward for serious hypersensitivity reactions. Avoid leakage outside the vein because extravasation can cause long-lasting brown skin discoloration.
Important warnings
Do not use ferric carboxymaltose in patients with known hypersensitivity to ferric carboxymaltose or formulation components. Serious hypersensitivity reactions, including anaphylactic reactions, hypotension and collapse, can occur; appropriate emergency treatment must therefore be immediately available during administration. Ferric carboxymaltose can cause severe or prolonged hypophosphatemia (low blood phosphate), sometimes leading to osteomalacia, fractures or hospitalization. Phosphate should be assessed as clinically indicated, particularly in people at risk and before repeat treatment within three months. Risk factors include vitamin D deficiency, malnutrition, hyperparathyroidism, inflammatory bowel disease and some malabsorption disorders. Blood pressure may rise temporarily after administration and should be monitored. Extravasation can cause persistent brown discoloration of the skin.
Side effects and monitoring
Common adverse effects reported with ferric carboxymaltose include nausea, temporary increases in blood pressure, flushing, dizziness, injection-site reactions, redness and hypophosphatemia. Serious or less common reactions include severe hypersensitivity or anaphylaxis, marked hypotension, angioedema, breathing difficulty, syncope and clinically significant hypophosphatemia. Seek urgent medical attention for difficulty breathing, swelling, collapse or other signs of a severe allergic reaction. Persistent or new fatigue, muscle weakness or pain, bone or joint pain after treatment can be symptoms of low phosphate and should be reported. Patients should be observed for hypersensitivity for at least 30 minutes after administration; blood pressure and, when indicated, serum phosphate should be monitored.
Pregnancy
Ferric carboxymaltose should be used during pregnancy only after the healthcare professional considers the maternal need and potential fetal risks. Available human data are insufficient to establish the risk of major birth defects or miscarriage. Severe maternal hypersensitivity or circulatory reactions to intravenous iron may cause fetal bradycardia, particularly during the second or third trimester. Untreated iron deficiency anemia during pregnancy also carries maternal and fetal risks.
Breastfeeding
Available evidence indicates that iron from ferric carboxymaltose is present in breast milk. Reported constipation and diarrhea in breastfed infants have not been established as being caused by exposure through breast milk, and available evidence considers ferric carboxymaltose compatible with breastfeeding when clinically required. The mother's treatment need and the benefits of breastfeeding should be considered together.
Food and drink
No food-related administration requirement is established because ferric carboxymaltose is administered intravenously rather than taken by mouth.
Storage
Store at controlled room temperature, 20°C to 25°C, with permitted excursions from 15°C to 30°C. Do not freeze. These conditions are verified for the referenced ferric carboxymaltose 50 mg/mL formulation; product-specific Ferium carton instructions should take precedence if they differ.
Frequently asked questions
How long does it take to feel better after a ferric carboxymaltose infusion?
The response varies according to the severity and cause of iron deficiency. The medicine replenishes available iron, but improvement in symptoms and blood measurements is not necessarily immediate; follow-up should be based on the treating clinician's plan.
Why might I feel unusually tired or achy after ferric carboxymaltose?
Persistent or worsening fatigue, muscle weakness or pain, and bone or joint pain can be symptoms of hypophosphatemia, an important adverse effect of ferric carboxymaltose. Contact your healthcare professional if these symptoms develop, as a blood phosphate test may be appropriate.
Can ferric carboxymaltose cause low phosphate even after one infusion?
Yes. Symptomatic hypophosphatemia has been reported after both single and repeated doses, including in people whose phosphate was normal before treatment. Severe or prolonged cases can cause osteomalacia and fractures.
Do I need to be monitored after Ferium is given?
Yes. Intravenous ferric carboxymaltose should be given where serious allergic reactions can be treated promptly, with observation during administration and for at least 30 minutes afterward until clinically stable. Blood pressure should also be monitored, and phosphate monitoring is appropriate in specified at-risk or repeat-treatment situations.
Can I inject Ferium myself at home?
No. This is an intravenous iron medicine that should be prepared and administered by an appropriately trained healthcare professional. Serious hypersensitivity reactions can occur, so suitable monitoring and emergency treatment must be available.
Can ferric carboxymaltose be used while breastfeeding?
It may be used when clinically appropriate. Iron is present in breast milk after treatment, but available evidence has not identified serious adverse reactions in breastfed infants attributable to ferric carboxymaltose exposure.
Can Cheap Generic Med ship Ferium to the United States?
Cheap Generic Med serves the United States under its international shipping model. Delivery is typically estimated at 10–14 business days after dispatch, but customs or carrier delays may extend transit; prescription and personal-import requirements can also apply.
Will my Ferium shipment have tracking?
Under the standard Cheap Generic Med fulfilment model, tracked international shipping is used and a tracking number should be provided after dispatch. New tracking numbers may take 24–72 hours to begin showing movement in the carrier system.
Sources
Medical information notice: This information does not replace advice from a qualified healthcare professional. Use prescription medicine only as directed by the prescriber and the approved product information.
| Active Ingredients | Ferric Carboxymaltose |
|---|---|
| Manufacturer | Emcure Pharmaceuticals |
| Packaging | Qty |
| strength | 50mg |
| Delivery Time | 6 To 15 days |
Related products
Danogen 200 Mg (Danazol)
Danogen 50 Mg (Danazol)
Duvadilan Retards 40 Mg (Isoxsuprine Hcl)
Evalon 15 gm (Estriol)
Femilon (0.02+0.15) Mg (Estradiol)
Reviews
There are no reviews yet.